Budget 2023Budget 2023


  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
Live: Live: President's Budget address
Budget 2023
Budget 2023

Gland, Cipla, Sun Pharma top picks; too soon to decipher new COVID opportunity: Sanford Bernstein's Nithya Balasubramanian

China is a very different economy and its vaccination coverage is lower while infection rate is higher than India's, says Balasubramanian

December 23, 2022 / 05:53 PM IST
Representative Image

Representative Image

  • bselive
  • nselive
Todays L/H

Gland Pharmaceuticals, Cipla and Sun Pharma are the top picks from the pharma pack of stocks for Sanford Bernstein, said Director Nithya Balasubramanian in an exclusive interview with CNBC-TV18.

''Sun Pharma is moving away from the pack given their exposure to US specialty which seems to be doing well and Cipla is moving because of their complex generic pipeline in the US, where we see material opportunities to play out in the next few years,'' Balasubramanian told CNBC-TV18.

Also Read: For pharma, success in 2023 lies in 'simpler regulation, innovation mindset'

''Gland Pharma has corrected quite a bit. We think the market is unwilling to appreciate the resilience in the company's business model. Their B2B business affords a few luxuries such as slightly lesser price erosion and the ability to grow the base.'' she added.